Leerink Partners Starts Agomab Therapeutics (AGMB) at Outperform
Tweet Send to a Friend
Leerink Partners initiates coverage on Agomab Therapeutics (NASDAQ: AGMB) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
